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Abstract
Purpose Alteration in fascial tissue collagen composition represents a key factor in hernia etiology and recurrence. Both 
resorbable and non-resorbable meshes for hernia repair are currently used in the surgical setting. However, no study has 
investigated so far the role of different implant materials on collagen deposition and tissue remodeling in human fascia. The 
aim of the present study was to develop a novel ex vivo model of human soft tissue repair mesh implant, and to test its suit-
ability to investigate the effects of different materials on tissue remodeling and collagen composition.
Methods Resorbable poly-4-hydroxybutyrate and non-resorbable polypropylene mesh implants were embedded in human 
abdominal fascia samples, mimicking common surgical procedures. Calcein-AM/Propidium Iodide vital staining was used 
to assess tissue vitality. Tissue morphology was evaluated using Mallory trichrome and hematoxylin and eosin staining. 
Collagen type I and III expression was determined through immunostaining semi-quantification by color deconvolution. All 
analyses were performed after 54 days of culture.
Results The established ex vivo model showed good viability at 54 days of culture, confirming both culture method feasibil-
ity and implants biocompatibility. Both mesh implants induced a disorganization of collagen fibers pattern. A statistically 
significantly higher collagen I/III ratio was detected in fascial tissue samples cultured with resorbable implants compared to 
either non-resorbable implants or meshes-free controls.
Conclusion We developed a novel ex vivo model and provided evidence that resorbable polyhydroxybutyrate meshes display 
better biomechanical properties suitable for proper restoration in surgical hernia repair.
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Introduction
Reinforcement of the abdominal wall with mesh implants 
is the most widely applied and established procedure in 
abdominal hernia surgical repair procedures. Both non-
resorbable and fully resorbable soft tissue repair implants 
are currently available. The latter accounts for the strength of 
a synthetic mesh, and shows the remodeling characteristics 
of a biologic graft. However, all meshes inevitably cause a 
foreign body reaction which affects collagen deposition, and 
in particular the type I/type III collagen ratio. This further 
alters connective tissue strength due to a delayed induction 
in collagen I conversion from immature collagen III [1, 2]. 
Changes in this ratio affects biomechanical strength and 
stability in already injured fascial tissue and may therefore 
increase the risk of hernia recurrence.
Collagen type I is indeed the characteristic component 
of mature scars or fascial tissues, while collagen type III 
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represents the mechanically unstable, less cross-linked sub-
type, synthesized during early wound healing stages [3].
Several studies already showed that the unbalanced ratio 
between the two collagen types might represent one of the 
main pathogenetic aspects of hernias’ development, with the 
lower tensile strength of collagen type III being a major fac-
tor in disease development and recurrence risk [4–6]. A first 
study reported diminished collagen content in the sheath of 
the rectus abdominis muscles as a direct or indirect cause 
of inguinal hernias development [7]. Moreover, immuno-
histochemistry analysis revealed a decrease in collagen I/III 
ratio in the fascial tissues of patients with hernias compared 
to healthy controls [8, 9]. It has also been suggested that 
individuals with abnormalities in collagen production might 
have a higher chance of developing hernias [10]. Consist-
ently, systemic increase in the synthesis of type III collagen 
may result in reduced collagen fibril assembly in the abdom-
inal wall, eventually leading to herniation [11]. Altogether, 
these findings indicate the dependence of abdominal wall 
mechanical stability on collagen composition.
Although both preclinical and clinical studies showed 
that distribution and quantity of the synthesized collagen 
is directly influenced by the type of mesh implant, it is still 
not clear if the latter has any influence on collagen content 
composition.
To address this point, we developed a pilot study aimed to 
assess the feasibility of a novel ex vivo model of abdominal 
hernia mesh implant, to determine the effects of two differ-
ent mesh implant materials (resorbable poly-4-hydroxybu-
tyrate and non-resorbable polypropylene) on collagen pro-
duction and fascial tissue remodeling in vitro. In particular, 
we developed and tested for the first time a novel tissue cul-
ture model, in which tissue samples from a small cohort of 
patients were cultured for 54 days in the presence of different 
mesh implant materials, and both vitality and collagen I vs 
collagen III deposition were evaluated.
Samples and methods
Fascial tissue samples
A total of 7 consecutive patients undergoing open abdomi-
nal procedures for other reasons were enrolled for the study 
at Sant’Agostino-Estense hospital in Baggiovara (Modena, 
Italy). Adult patients (older than 18 years) with indication 
to open surgery for both benign and oncological pathologies 
in elective setting were included; BMI > 30, a proven clini-
cal immunodeficient status, emergency procedures, previous 
abdominal surgery and the presence of primary or ventral 
abdominal wall hernias represented criteria of exclusion.
In particular, at the time of the procedure, under general 
anesthesia a median incision was performed, subcutaneous 
tissue was dissected and aponeurosis was exposed; biopsy of 
surgical specimen was taken in correspondence of the sec-
tion margin of posterior fascia on the midline without using 
the electrical cautering.
Considering the early explorative nature of this study, 
sample size was determined based on the aim to show pre-
liminary methods feasibility and to obtain an estimate of 
effect size. No statistical power analysis was applied.
Subject demographics are summarized in Table 1.
Mesh implants
Surgical mesh implants, intended for soft tissue repair, were 
developed by Bard (CR Bard Inc-BD Medical, USA).
Implants consisted in two different types of materials, 
one being a monofilament fully resorbable macroporous 
poly-4-hydroxybutyrate (P4HB) mesh (Phasix™) while the 
other a non-resorbable monofilament polypropylene mesh 
(Perfix™).
Samples handling, ex vivo mesh implant and culture 
conditions
Fascia samples were shipped right after surgical explant in 
45 ml RPMI medium supplemented with 10% FBS and 1% 
Penicillin–Streptomycin (EuroClone, Milan, Italy) at room 
temperature.
Samples were immediately divided into three pieces 
(measuring approximately 0.6 × 0.6 cm) at the time of arrival 
using a scalpel, to be then processed as follows: (i) resorba-
ble Phasix™ mesh implantation (R), (ii) non-resorbable Pre-
fix™ mesh implantation (NR) or (iii) mesh-free controls (C). 
Briefly, small meshes cut-outs were put in contact with fas-
cia samples in a “sandwich-like” configuration and secured 
using the smallest amount of cyanoacrylate-based tissue 
adhesive (PeriAcryl 90 HV, Gluestich Inc, Canada) as rep-
resented in Fig. 1. This type of adhesive allows proper mesh 
fixation, showing good tissue integration and effective short-
term biocompatibility both in vivo and in vitro, and therefore 
represents a feasible alternative approach to fix mesh instead 
of using suture [12, 13]. Moreover, cyanoacrylate-based 
Table 1  Subjects demographics
Subject ID Sex (male/female) Age (years)
GB 001 Male 85
GB 002 Male 72
GB 003 Female 81
GB 004 Male 70
GB 005 Male 72
GB 006 Female 74
GB 007 Female 80
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adhesive is also specifically used in the clinical setting as a 
common method for soft tissue repair mesh fixation and it 
was therefore selected as the most appropriate method for 
mesh fixation.
Samples which didn’t undergo mesh implant were con-
sidered as controls (C) and underwent the application of 
cyanoacrylate adhesive in order to achieve the same three-
dimensional model conformation applied in the other study 
conditions.
All samples were kept fully submerged in 20 ml RPMI 
medium supplemented with 10% FBS (EuroClone), 1% 
Amphotericin-B (EuroClone, Italy) (2.5 mg/L) and 1% 
Penicillin–Streptomycin solution (EuroClone) at 37 °C and 
5%  CO2 in suspension culture flasks. Culture medium was 
replaced weekly with fresh one. All the above-mentioned 
procedures were performed under sterile conditions.
Samples viability assessment
Samples viability was evaluated at the time of samples 
arrival (T0) and 54 days following meshes implant (54 days) 
using Calcein-AM/Propidium Iodide vital staining. Mesh-
free samples (C) were also evaluated at the two overmen-
tioned time points.
Calcein-AM selectively stains viable cells in bright green, 
while Propidium Iodide (PI) is used to identify dead cells 
as bright red.
Briefly, samples portions measuring approximately 
0.20 × 0.20 cm, were obtained at each time point and for 
each condition using a scalpel under sterile conditions. They 
were then incubated in 2 μg/mL Calcein-AM (Molecular 
Probes, USA) and 10 μg/mL Propidium Iodide (Sigma-
Aldrich, USA) in PBS at 37 °C for one hour in 24-wells 
culture plates (500 ml/well).
Tissue samples were then washed twice in PBS to remove 
excess staining.
Images were acquired using a fluorescence micro-
scope system and the RS Image Software (Photometrics, 
USA). Calcein was detected at 450 nm/490 nm, while PI at 
510 nm/530 nm.
Intensity of the two fluorescence channels was quantified 
separately as integrated density (IntDen) and subjected to 
background subtraction using ImageJ (National Institutes of 
Health-NIH, USA).
Fluorescence quantification was performed in three ran-
domly selected 10X microscopic fields per sample, in each 
culture condition detailed above. In order to evaluate culture 
conditions effect on samples viability, results at 54 days were 
expressed as percentage of  T0 control samples.
Mallory trichrome staining
In order to evaluate total collagen composition of fascia 
samples, Mallory trichrome staining was performed. This 
staining allows the identification of collagen fibers in blue 
and muscle fibers in red.
Meshes implants were carefully removed from samples 
using a scalpel, taking care to avoid tissue damage. C, R and 
NR samples portions measuring approximately 0.2 × 0.2 cm, 
fixed in 4% formaldehyde for 12 h, were dehydrated and 
paraffin embedded. After sectioning at 7 μm, air-dried slides 
were de-paraffinized and rehydrated.
Fig. 1  Fascia samples ex-vivo 




Sections were then placed into 1% acid fuchsin solution 
for 3 min, followed by 2 min in 1% phosphomolybdic acid 
and 15 min in Mallory staining solution (2% Orange G, 0.5% 
methyl blue and 2% oxalic acid in distilled water). Each 
staining step was followed by a quick rinse in distilled water. 
Section were then dehydrated and differentiated in ethanol, 
cleared with xylene and mounted using a resinous medium.
Hematoxylin and eosin staining
Standard Hematoxylin and Eosin staining was performed on 
C, R and NR samples at T0 and 54 days in order to qualita-
tively evaluate tissue morphology. Samples were processed 
as previously described for Mallory staining and sectioned 
at 7 μm.
Type I and type III collagen immunostaining
Type I and III collagen content was assessed in paraffin-
embedded 7 μm samples slices using the HRP-DAB Ultra-
vision LP Detection System kit (Thermo Scientific, USA) 
following manufacturer’s instruction.
A heat-induced microwave antigen retrieval protocol 
(4 heating steps at 700 W, 5 min each) in Sodium Citrate 
buffer (Ph 6.0) was performed before the immunostaining 
procedure.
Slides were incubated overnight at 4 °C with 50 μl of 
primary antibodies (rabbit polyclonal anti-human type I 
collagen-ab34710 or mouse monoclonal anti-human type III 
collagen-ab6310, both provided by Abcam) diluted 1:500 in 
Ultra V Block solution 1:10 in PBS.
Finally, all sections were counterstained with Mayer’s 
Hematoxylin, dehydrated in ethanol, cleared in xylene and 
mounted using a resinous medium.
Negative control sections were prepared by omitting the 
primary antibody in order to ensure staining specificity. In 
all cases, control sections showed no staining under micro-
scopic examination.
Immunostained slides were visualized using a Leica 
DMR light microscope paired with a Leica DC 200 CCD 
camera system and DCViewer v3.2 software for white bal-
ance and image acquisition.
Identical reagents, processing, DAB incubation time and 
image acquisition settings were applied for all slides.
Images were then exported in ImageJ v1.51 (National 
Institutes of Health-NIH, USA) and background subtraction 
(rolling ball radius = 50.0 pixels) was performed.
Immunostaining intensity was quantified with Fiji soft-
ware [14] using the built-in H DAB color deconvolution vec-
tor based on stain-specific red–green–blue (RGB) absorption 
to isolate the brown DAB from hematoxylin counterstain and 
unspecific background [15, 16].
Staining intensities were calculated as grey-scale val-
ues and converted in optical density (OD) using the for-
mula log(Max intensity/Min intenisty).
For each subject, five randomly selected 40X whole-
stained microscopic fields per sample condition were cho-
sen and quantified.
Data analysis
Data statistical and graphical analysis was carried out 
using Origin V.8 (OriginLab Corporation, USA) and 
GraphPad Prism 6 software (GraphPad Software, USA).
Results were expressed as mean ± SEM. Since data 
represent repeated measurements within each study con-
dition and are normally distributed, statistical compari-
sons between multiple groups were performed using the 
“Repeated Measure ANOVA” (RA) test, followed by Tuk-




Tissue samples vital staining revealed the presence of via-
ble cells at both time points in all the conditions (Fig. 2a). 
At 54 days culture, all samples conditions did not show 
any statistically significant decrease in cell viability when 
compared to T0 samples. No statistically significant differ-
ences in cell viability were also observed between the two 
different types of mesh implants (Fig. 2b). This staining 
technique also revealed the appearance of elongated viable 
fibroblast-like cells within all sample at 54 days.
Tissue morphology
Both Mallory trichrome staining and Hematoxylin and 
Eosin staining revealed a diffuse fibrous appearance in all 
sample conditions, with collagen representing the majority 
of the microscopic field (Fig. 3).
Interestingly, samples which underwent mesh 
implants placement showed an architectural collagen pat-
tern distortion with tangled and twisted fibers orientation 
when compared to mesh-free samples wavy parallel bun-
dles (Fig. 3).
Moreover, samples showed minor cellular component 
within collagen fibers, consisting mainly of elongated 
fibroblastoid cells. Muscle fibers presence, visible as red 
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staining using Mallory trichrome, was rare and represented 
just a minimal portion of the samples (Fig. 3).
Type I/III collagen immunostaining
Positive immunostaining for type I collagen appeared thick 
and heavy, with a widely distributed pattern in all samples 
(Fig. 3). Conversely, type III collagen immunostaining was 
lighter, sparser and unevenly distributed.
The semi-quantitative analysis of collagen immu-
nostaining (relative to both collagen I and collagen III) did 
not show any statistically significant difference between 
control mesh-free samples (C) at the two time points: T0 
and 54 days (data relative to the individual samples are 
shown in Table 2).
On the other hand, the semi-quantitative analysis on 
samples cultured ex vivo for 54 days after meshes fixation, 
showed a slight (1.08 ± 0.02 vs. 0.95 ± 0.04), although sta-
tistically significant (P = 0.027), increase in the collagen I/
III ratio in samples implanted with non resorbable meshes 
(NR) compared to samples in control culture conditions 
(C, i.e. no added meshes). A more evident (1.36 ± 0.05 
vs. 0.95 ± 0.04), highly statistically significant, increase in 
the collagen I/III ratio was observed in samples implanted 
with resorbable meshes (R), compared to C (P < 0.001). 
A statistically significant difference between R and NR 
conditions (1.36 ± 0.05 vs. 1.08 ± 0.02, P < 0.001) also 
Fig. 2  Samples viability 
assessment using Calcein-AM/
Propidium Iodide vital staining. 
a Representative single-channel 
and merged images (10× mag-
nification, scale bar = 100 µm); 
b Fluorescence intensity 
calculated as Integrated Density 
(IntDen) and presented as 
T0 control percentage. Bars 
are representative of the 
mean ± SEM of three randomly 
selected 10X microscopic fields 
per condition for each sample 
(n = 7). C samples which did not 
undergo mesh implant, mesh-
free controls, R fully resorbable 
poly-4-hydroxy-butyrate mesh 
implant, NR non-resorbable 
polypropylene mesh implant, T0 
time of tissue samples arrival, 




emerged (Fig. 4). In particular, as evident in Table 2, while 
collagen I staining intensity was significantly higher in the 
R group compared to both C and NR groups, the staining 
intensity of collagen III was significantly lower in the R 
group compared to controls (C).
Discussion
In the present study we provide for the first time evidence of 
the suitability of a novel ex vivo tissue model of abdominal 
hernia mesh implant to determine the effects of two different 
mesh implant materials (resorbable poly-4-hydroxybutyrate 
and non-resorbable polypropylene) on collagen production 
and fascial tissue remodeling in vitro. First evidence was 
obtained that the in vitro culture of human fascial tissues 
with the fully-resorbable mesh implants increases the col-
lagen I/III ratio towards higher values compared to non-
resorbable ones, which suggests a better performance of 
resorbable meshes in tissue remodeling.
As expected from previously published in  vivo data 
[17], both resorbable and non-resorbable meshes appeared 
intact and with no signs of reabsorption after 54 days from 
implantation.
Evaluation of fascia samples tissue morphology revealed 
an organized parallel wavy collagen fibers pattern in mesh-
free samples conditions at both time points, while a more 
disorganized and tangled orientation appeared in both mesh 
implants conditions. This change is representative of fascial 
scar tissue formation which plays a key role in surgical 
implant-induced abdominal wall reinforcement, along with 
neovascularization and deposition of extracellular matrix.
The developed culture method showed no significant 
impact on collagen content modification, as confirmed by 
immunostaining quantification results in mesh-free sam-
ples at the two time intervals. This results also confirms 
the possibility to assess collagen content in fascia tissue 
specimens despite innate primary samples variability from 
donor to donor.
The absence of significant cell viability loss between 
the two time points (T0 and 54 days after meshes implan-
tation) confirms the short-term biocompatibility of both 
mesh materials. This also indicates the feasibility of the 
tridimensional culture method developed for this study, 
possibly allowing its establishment as a novel ex vivo 
model of surgical soft tissue repair.
Moreover, the appearance of viable elongated cells 
within the samples at 54 days may represent the presence 
of proliferating fibroblasts which usually occurs during the 
first stages of wound healing and allows collagen deposi-
tion at the site of mesh implantation.
However, it has to be noticed that collagen deposition, 
fibrosis and tissue remodeling are usually evaluated at longer 
mid-term time intervals in vivo (12–24 weeks from implan-
tation) and any ex-vivo model obviously lacks in several 
biological mechanisms which could affect collagen deposi-
tion and foreign body response in a full organism.
Fig. 3  Representative immuno-
histochemistry (IHC), Hema-
toxylin and Eosin (H&E) and 
Mallory trichrome staining 
images (40X magnification, 
scale bar = 100 µm). C samples 
which did not undergo mesh 
implant, mesh-free controls, R 
fully resorbable poly-4-hydroxy-
butyrate mesh implant, NR 
non-resorbable polypropylene 
mesh implant, COL I collagen 
I staining, COL III collagen 
III, T0 time of tissue samples 




The higher collagen I/III ratio observed in the resorbable 
mesh group when compared with both mesh-free samples 
and the non-resorbable mesh group, may be likely caused by 
differences in implant materials biocompatibility. The higher 
cell affinity of butyrate has already been demonstrated spe-
cifically compared to polypropylene [18–21]. Moreover, sur-
gical meshes colonization and subsequent collagen I deposi-
tion by fibroblasts is a well-known process which has been 
observed both in vivo and in vitro [22, 23]. In this scenario, 
resorbable P4HB meshes might allow fibroblasts coloniza-
tion, their proliferation, activation and the ensuing deposi-
tion of mature collagen once in contact with the fascial tis-
sue, at higher levels compared to polypropylene-containing 
meshes. This could eventually lead to the observed increase 
in collagen I/III ratio, which is representative of functional 
fascial tissue repair. Overall, the results we obtained confirm 
previously published short- and mid-term in vivo findings 
suggesting a more favorable long-term tissue remodeling 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 4  Collagen I/III immunostaining ratio in different samples condi-
tions after 54 days of culture. Results are expressed as optical density 
(OD). Data are reported as mean ± SEM (n = 7 subjects). For each 
subject, the mean OD of five randomly selected 40X whole-stained 
microscopic fields for each sample condition was calculated. Statisti-
cal comparisons between multiple groups were performed using RA 
test with Tukey’s post-hoc test. Differences with P < 0.05 were con-
sidered significant. C samples which did not undergo mesh implant, 
mesh-free controls, R fully resorbable poly-4-hydroxy-butyrate mesh 
implant, NR non-resorbable polypropylene mesh implant, T0 time of 
tissue samples arrival, 54d 54 days culture from meshes implantation; 
*** = P < 0.001; * = P < 0.05
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Finally, considering the key role of collagen I/III ratio in 
influencing connective tissue biomechanical functionality 
and its reported decrease in fascia specimens from patients 
with abdominal hernia, our results suggest how fully resorb-
able P4HB mesh implants could allow for higher quality 
tissue repair and functionality restoration if compared to 
monofilament polypropylene.
In conclusion, the present study offers valuable prelimi-
nary results about surgical meshes-induced tissue remod-
eling in fascia samples and highlights the feasibility and 
promising role of the proposed ex vivo model.
The results we obtained definitely warrant further valida-
tion in a larger and independent sample cohort, which also 
includes fascia samples from patients with abdominal hernia 
and hernia-prone subjects (such as obese, immunodepressed 
and diabetic patients). This will contribute to further confirm 
the utility of the proposed model in studying tissue remod-
eling in surgical hernia repair.
In addition, it will be possible to apply the ex vivo model 
we developed in the present study, to mechanotransduction 
studies, applying exogenous mechanical forces together with 
different meshes implantation. This will eventually allow for 
a more complex biomechanical characterization of mesh-
induced soft tissue repair, potentially validating the use of 
the novel ex vivo model we developed to predict whether a 
certain tissue specimen from patients will remodel differ-
ently, depending on the type of mesh material.
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